Beta adrenergic-mediated vasodilator response to insulin in the human forearm

MA Creager, CS Liang and JD Coffman

Insulin, in doses sufficient to cause systemic hypoglycemia, decreases vascular resistance; however, a vasoactive effect of insulin in humans, in the absence of hypoglycemia, is unknown. Venous occlusion strain gauge plethysmography was utilized to determine forearm blood flow (FBF) and forearm vascular resistance (FVR) during incremental intra- arterial infusion of insulin (0.1, 0.5 and 1.0 mU/kg/min) in seven normal subjects. With the increasing doses of insulin, FBF increased 55, 76 and 145% and FVR decreased 30, 42 and 58%, respectively. Systemic glucose concentration decreased only during the highest dose insulin infusion. In eight subjects who received insulin during euglycemic glucose clamping, FVR also decreased. Therefore, it was demonstrated that insulin dilates the forearm vasculature in the absence of hypoglycemia. In order to determine whether the vasodilatory effect of insulin was mediated by the sympathetic nervous system, plasma levels of epinephrine and norepinephrine were measured. During the incremental insulin infusions, norepinephrine levels did not change, but epinephrine concentration increased during the 1.0 mU/kg/min infusion when hypoglycemia developed. Furthermore, 21 subjects were pretreated with intra-arterial phentolamine, propranolol or the combination of phentolamine and propranolol. Phentolamine did not potentiate the fall in FVR during insulin administration; however, propranolol attenuated or completely inhibited the changes in FBF and FVR. During combined alpha and beta adrenergic blockade, insulin increased FBF and decreased FVR only during the higher dose insulin infusions. It is concluded that insulin causes forearm vasodilation primarily via a beta adrenergic mechanism. In addition, at the higher doses used in this study, insulin may decrease FVR directly or by a mechanism other than adrenergic stimulation.

Volume 235, Issue 3, pp. 709-714, 12/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J.-a Kim, M. Montagnani, K. K. Koh, and M. J. Quon Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms Circulation, April 18, 2006; 113(15): 1888 - 1904. [Abstract] [Full Text] [PDF]

				S. M Gardiner, D. J. R. Nunez, P. G. Baer, K. K. Brown, and T. Bennett Regional Hemodynamic Effects of the N-(2-Benzoylphenyl)-L-tyrosine Peroxisome Proliferator-Activated Receptor-{gamma} Ligand, GI 262570 [(S)-2-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic Acid], in Conscious Rats J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1226 - 1233. [Abstract] [Full Text] [PDF]

				M. F. Saad, M. Rewers, J. Selby, G. Howard, S. Jinagouda, S. Fahmi, D. Zaccaro, R. N. Bergman, P. J. Savage, and S. M. Haffner Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study Hypertension, June 1, 2004; 43(6): 1324 - 1331. [Abstract] [Full Text] [PDF]

				S. Enoksson, S. K. Caprio, F. Rife, G. I. Shulman, W. V. Tamborlane, and R. S. Sherwin Defective Activation of Skeletal Muscle and Adipose Tissue Lipolysis in Type 1 Diabetes Mellitus during Hypoglycemia J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1503 - 1511. [Abstract] [Full Text] [PDF]

				Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance Hypertension, November 1, 2002; 40(5): 679 - 686. [Abstract] [Full Text] [PDF]

				L. H. Clerk, S. Rattigan, and M. G. Clark Lipid Infusion Impairs Physiologic Insulin-Mediated Capillary Recruitment and Muscle Glucose Uptake In Vivo Diabetes, April 1, 2002; 51(4): 1138 - 1145. [Abstract] [Full Text] [PDF]

				C. A. Schroeder Jr., Y.-L. Chen, and E. J. Messina Inhibition of NO synthesis or endothelium removal reveals a vasoconstrictor effect of insulin on isolated arterioles Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H815 - H820. [Abstract] [Full Text] [PDF]

				S. J. Cleland, J. R. Petrie, S. Ueda, H. L. Elliott, and J. M. C. Connell Insulin-Mediated Vasodilation and Glucose Uptake Are Functionally Linked in Humans Hypertension, January 1, 1999; 33(1): 554 - 558. [Abstract] [Full Text] [PDF]

				Y. Nishimoto, Y. Miyazaki, Y. Toki, R. Murakami, M. Shinoda, A. Fukushima, and H. Kanayama Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1624 - 1629. [Abstract] [Full Text] [PDF]

				D. Hasdai, D. R. Holmes Jr., D. M. Richardson, U. Izhar, and A. Lerman Insulin and IGF-I attenuate the coronary vasoconstrictor effects of endothelin-1 but not of sarafotoxin 6c Cardiovasc Res, September 1, 1998; 39(3): 644 - 650. [Abstract] [Full Text] [PDF]

				D. Hasdai, R. A. Rizza, D. R. Holmes Jr, D. M. Richardson, P. Cohen, and A. Lerman Insulin and Insulin-like Growth Factor-I Cause Coronary Vasorelaxation In Vitro Hypertension, August 1, 1998; 32(2): 228 - 234. [Abstract] [Full Text] [PDF]

				T. Heise, K. Magnusson, L. Heinemann, and P. T. Sawicki Insulin Resistance and the Effect of Insulin on Blood Pressure in Essential Hypertension Hypertension, August 1, 1998; 32(2): 243 - 248. [Abstract] [Full Text] [PDF]

				B. H. Sung, M. Ching, J. Izzo Jr, P. Dandona, and M. F. Wilson Insulin-Mediated Venodilation Is Impaired in Patients With High Cholesterol Hypertension, June 1, 1998; 31(6): 1266 - 1271. [Abstract] [Full Text] [PDF]

				S. B. Williams, A. B. Goldfine, F. K. Timimi, H. H. Ting, M.-A. Roddy, D. C. Simonson, and M. A. Creager Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo Circulation, May 5, 1998; 97(17): 1695 - 1701. [Abstract] [Full Text] [PDF]

				U. Scherrer and C. Sartori Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity Circulation, December 2, 1997; 96(11): 4104 - 4113. [Abstract] [Full Text]

				E. Bouskela, F. Z. G. A. Cyrino, N. Wiernsperger, and E. Bouskela Effects of Insulin and the Combination of Insulin Plus Metformin (Glucophage) on Microvascular Reactivity in Control and Diabetic Hamsters Angiology, June 1, 1997; 48(6): 503 - 514. [Abstract] [PDF]

				G. Lembo, G. Iaccarino, C. Vecchione, V. Rendina, L. Parrella, and B. Trimarco Insulin Modulation of ß-Adrenergic Vasodilator Pathway in Human Forearm Circulation, April 1, 1996; 93(7): 1403 - 1410. [Abstract] [Full Text]

				S. Taddei, A. Virdis, P. Mattei, A. Natali, E. Ferrannini, and A. Salvetti Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential Hypertension Circulation, November 15, 1995; 92(10): 2911 - 2918. [Abstract] [Full Text]

				S.-Z. Han, Y. Ouchi, H. Karaki, and H. Orimo Inhibitory Effects of Insulin on Cytosolic Ca2+ Level and Contraction in the Rat Aorta : Endothelium-Dependent and -Independent Mechanisms Circ. Res., October 1, 1995; 77(4): 673 - 678. [Abstract] [Full Text]

				T.G. Robinson and J.F. Potter Postprandial and Orthostatic Cardiovascular Changes After Acute Stroke Stroke, October 1, 1995; 26(10): 1811 - 1816. [Abstract] [Full Text]

				J. E. Hall, M. W. Brands, D. H. Zappe, W. N. Dixon, H. L. Mizelle, G. A. Reinhart, and D. A. Hildebrandt Hemodynamic and Renal Responses to Chronic Hyperinsulinemia in Obese, Insulin-Resistant Dogs Hypertension, May 1, 1995; 25(5): 994 - 1002. [Abstract] [Full Text]

				A. Grover, C. Padginton, M. F. Wilson, B. H. Sung, J. L. Izzo Jr, and P. Dandona Insulin Attenuates Norepinephrine- Induced Venoconstriction : An Ultrasonographic Study Hypertension, April 1, 1995; 25(4): 779 - 784. [Abstract] [Full Text]